Literature DB >> 2995450

Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.

K R Bridges, B R Smith.   

Abstract

Expression of the transferrin receptor on target cell lines has recently been implicated as a determinant of susceptibility to cytolysis by natural killer (NK) lymphocytes. We have examined this proposed relationship in several ways. First, K562 (a cell line highly vulnerable to NK lysis) cells were grown for 24 h in the iron chelator desferrioxamine. Under these conditions, the cells doubled their surface transferrin receptor expression as determined both by radioligand binding and surface binding of the OK-T9 monoclonal anti-transferrin receptor antibody. In contrast, cells grown for the same period of time in hemin halved their receptor expression. This fourfold change in transferrin receptor expression between the desferrioxamine-treated and hemin-treated cells produced no change in susceptibility to NK cytolysis. Second, HeLa (a cell line which in its native state is very resistant to NK cytolysis) cells were compared with K562 cells with respect to surface transferrin receptor expression. The difference in NK susceptibility of the two cell lines was not reflected in differences in transferrin receptor expression: the K562 cells expressed approximately 1.5 X 10(5) receptors per cell while HeLa cells expressed 2.0 X 10(5) receptors/cell. Third, infection of HeLa cells by measles virus greatly increased their susceptibility to NK lysis but produced no change in surface transferrin receptor expression. Furthermore, when measles-infected HeLa cells were grown for 6 d in medium supplemented with iron-saturated human transferrin they underwent a 50% reduction in receptor expression but no change in NK susceptibility. Finally, possible alterations in the surface expression of NK target antigens on modified cells were further assayed by their ability to serve as cold-target inhibitors of cytolysis of NK-sensitive target cells. We examined two groups of cells in which transferrin receptor expression was reduced. These were the transferrin-treated, measles-infected HeLa cells with the 50% receptor reduction, and K562 cells grown in medium containing hemin and iron salts where the reduction was five- to sixfold relative to control. In neither case was there a change in the apparent expression of NK target antigen(s). We conclude that there is a discordance between transferrin receptor expression and susceptibility to NK cytolysis in the model systems examined. Therefore, it is unlikely that the transferrin receptor per se is the target recognition structure for human NK cells, although a role in concert with other, as yet undefined molecules, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995450      PMCID: PMC423953          DOI: 10.1172/JCI112089

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells.

Authors:  B Alarcón; M Fresno
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

2.  Biosynthetic regulation of the human transferrin receptor by desferrioxamine in K562 cells.

Authors:  E Mattia; K Rao; D S Shapiro; H H Sussman; R D Klausner
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

3.  The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes.

Authors:  B J Iacopetta; E H Morgan
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

4.  Natural killer cells suppress human erythroid stem cell proliferation in vitro.

Authors:  K F Mangan; M E Hartnett; S A Matis; A Winkelstein; T Abo
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

5.  Target structure for natural killer cells: evidence against a unique role for transferrin receptor.

Authors:  M C Dokhélar; D Garson; U Testa; T Tursz
Journal:  Eur J Immunol       Date:  1984-04       Impact factor: 5.532

6.  The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.

Authors:  L A Holmberg; B A Miller; K A Ault
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  The transferrin cycle and iron uptake in rabbit reticulocytes. Pulse studies using 59Fe, 125I-labeled transferrin.

Authors:  M T Nuñez; J Glass
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

8.  Effect of iron chelators on the transferrin receptor in K562 cells.

Authors:  K R Bridges; A Cudkowicz
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

9.  Human natural cytotoxic lymphocytes: definition by a monoclonal antibody of a subset which kills an anchorage-dependent target cell line but not the K-562 cell line.

Authors:  M Rola-Pleszczynski; H Lieu
Journal:  Cell Immunol       Date:  1983-12       Impact factor: 4.868

10.  NK recognition of target structures: is the transferrin receptor the NK target structure?

Authors:  R A Newman; J F Warner; G Dennert
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

View more
  13 in total

1.  Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells.

Authors:  Rick K Huang; Nicole F Steinmetz; Chi-Yu Fu; Marianne Manchester; John E Johnson
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

2.  Different functional domains on the transferrin receptor molecule defined by monoclonal antibodies.

Authors:  J A Lopez Guerrero; J M Redondo; B Alarcón; F Sánchez-Madrid; M Rodríguez Moya; M Ortíz de Landazuri; C Bernabeu; M Fresno
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

Review 3.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies.

Authors:  C Agostini; L Trentin; R Zambello; M Luca; M Masciarelli; A Cipriani; G Marcer; G Semenzato
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

5.  Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer.

Authors:  H Benoist; L Comoe; P Joly; Y Carpentier; A Desplaces; J Dufer
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Natural killer cells in peripheral blood and the mixed lymphocyte response: interaction with the transferrin receptor.

Authors:  M Salmon; P A Bacon; S P Young
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

7.  Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes.

Authors:  R Zambello; T Chisesi; C Agostini; L Trentin; M Masciarelli; G Gasparotto; M Vespignani; G Casorati; R Foa; G Semenzato
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

8.  Single-Cell Droplet Microfluidic Screening for Antibodies Specifically Binding to Target Cells.

Authors:  Nachiket Shembekar; Hongxing Hu; David Eustace; Christoph A Merten
Journal:  Cell Rep       Date:  2018-02-20       Impact factor: 9.423

9.  Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.

Authors:  Nour M AlSawaftah; Nahid S Awad; Vinod Paul; Paul S Kawak; Mohammad H Al-Sayah; Ghaleb A Husseini
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

10.  Canine parvovirus-like particles, a novel nanomaterial for tumor targeting.

Authors:  Pratik Singh; Giuseppe Destito; Anette Schneemann; Marianne Manchester
Journal:  J Nanobiotechnology       Date:  2006-02-13       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.